ARS Pharmaceuticals Inc
NASDAQ:SPRY 4:00:00 PM EDT
Market Cap (Intraday) | 700.48M |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $7.16 |
50-Day MA | $7.34 |
200-Day MA | $5.40 |
ARS Pharmaceuticals Inc Stock, NASDAQ:SPRY
11682 El Camino Real, Suite 120, San Diego, California 92130
United States of America
Phone: +1.858.771.9307
Number of Employees: 90
Description
ARS Pharmaceuticals, Inc. engages in developing neffyâ„¢, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. The company is headquartered in San Diego, CA.